参考文献

［1］JACOB S，PANAICH SS，ZALAWADIYA SK，et al.Phantom shocks unmasked：clinical data and proposed mechanism of memory reactivation of past traumatic shocks in patients with implantable cardioverter def i brillators.J Interv Card Electrophysiol，2012，34（2）：205-213.

［2］MISHKIN JD，SAXONHOUSE SJ，WOO GW，et al.Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-def i brillator discharge：time to go beyond the initial shock.J Am Coll Cardiol，2009，54（22）：1993-2000.

［3］WILKOFF BL，COOK JR，EPSTEIN AE，et al.Dual-chamber pacing or ventricular backup pacing in patients with an implantable def i brillator：the Dual Chamber and VVI Implantable Def i brillator（DAVID）Trial.JAMA，2002，288（24）：3115-3123.

［4］WILKOFF BL，FAUCHIER L，STILES MK，et al.2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.Heart Rhythm，2016，13（2）：e50-86.

［5］WATHEN M.Implantable cardioverter defibrillator shock reduction using new antitachycardia pacing therapies.Am Heart J，2007，153（4 Suppl）：44-52.

［6］WATHEN MS，SWEENEY MO，DEGROOT PJ，et al.Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease.Circulation，2001，104（7）：796-801.

［7］WATHEN MS，DEGROOT PJ，SWEENEY MO，et al.Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators：Pacing Fast Ventricular Tachycardia Reduces Shock Therapies（PainFREE Rx II）trial results.Circulation，2004，110（17）：2591-2596.

［8］GULIZIA MM，PIRAINO L，SCHERILLO M，et al.A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter def i brillators：the PITAGORA ICD trial.Circ Arrhythm Electrophysiol，2009，2（2）：146-153.

［9］GILLIS AM，LEITCH JW，SHELDON RS，et al.A prospective randomized comparison of autodecremental pacing to burst pacing in device therapy for chronic ventricular tachycardia secondary to coronary artery disease.Am J Cardiol，1993，72（15）：1146-1151.

［10］SCHAUMANN A，VON ZUR MüHLEN F，HERSE B，et al.Empirical versus tested antitachycardia pacing in implantable cardioverter def i brillators：a prospective study including 200 patients.Circulation，1998，97（1）：66-74.

［11］DILLON SM.Synchronized repolarization after defibrillation shocks.A possible component of the def i brillation process demonstrated by optical recordings in rabbit heart.Circulation，1992，85（5）：1865-1878.

［12］SHUKLA HH，FLAKER GC，JAYAM V，et al.High def i brillation thresholds in transvenous biphasic implantable def i brillators：clinical predictors and prognostic implications.Pacing Clin Electrophysiol，2003，26（1 Pt 1）：44-48.

［13］TOKANO T，PELOSI F，FLEMMING M，et al.Long-term evaluation of the ventricular def i brillation energy requirement.J Cardiovasc Electrophysiol，1998，9（9）：916-920.

［14］PELOSI F Jr，ORAL H，KIM MH，et al.Effect of chronic amiodarone therapy on def i brillation energy requirements in humans.J Cardiovasc Electrophysiol，2000，11（7）：736-740.

［15］SHIH MJ，KAKODKAR SA，KAID Y，et al.Reassessing risk factors for high def i brillation threshold：The EF-SAGA risk score and implications for device testing.pacing Clin Electrophysiol，2016，39（5）：483-489.